Tomer Madmon

Title: Tomer Madmon: Innovator in Neurodegenerative Disease Treatment

Introduction

Tomer Madmon is a notable inventor based in Kfar Yona, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. His work focuses on developing innovative formulations that enhance the efficacy of existing medications.

Latest Patents

Tomer Madmon holds 1 patent for his invention titled "Extended release formulations of rasagiline and uses thereof." This patent provides various pharmaceutical compositions, specifically designed for oral administration. These formulations are intended for the extended release of active compounds that are useful in treating neurodegenerative diseases, especially Parkinson's disease, and injuries to the nervous system. The active compound in these compositions is preferably selected from N-propargyl-1-aminoindan, an enantiomer thereof, or a pharmaceutically acceptable salt thereof, with rasagiline being the most preferred option.

Career Highlights

Throughout his career, Tomer has demonstrated a commitment to advancing medical science through innovative research and development. His work has the potential to significantly improve the quality of life for patients suffering from debilitating conditions.

Collaborations

Tomer collaborates with esteemed colleagues, including Yoram Sela and Nurit Livnah, who contribute to his research efforts and help bring his inventions to fruition.

Conclusion

Tomer Madmon is a dedicated inventor whose work in pharmaceutical formulations is paving the way for new treatments in neurodegenerative diseases. His innovative approach and collaboration with talented professionals highlight the importance of teamwork in advancing medical science.